A
AUTL
AUTOLUS THERAPEUTICS PLC
1.680
-0.020-1.18%Pre Market: 1.630 -0.050 -2.96%05:50 05/27 EDT
OPEN/PREV CLOSE1.740/1.700
TODAY RANGE1.670-1.740
VOL20.45K
MARKET CAP447.14M
52 WEEK RANGE1.175-2.700
AVG VOL (3M)1.62M
% TURNOVER0.40%
TURNOVER0
P/E (TTM)-1.5474
% RANGE4.12%
EPS(TTM)-1.0857
P/E(FORWARD)0.1039
P/B1.390
BVPS1.302
DIVIDEND--
P/S41.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP324.40M
SHARES OUTSTANDING266.16M
NEXT EARNINGS08/10-08/14
FREE FLOAT193.10M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/19 00:01
Autolus Therapeutics Signals Turning Point in Earnings
Benzinga·05/18 16:33
Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday
TipRanks·05/15 11:12
Wells Fargo Remains a Buy on Autolus Therapeutics (AUTL)
TipRanks·05/15 06:56
Goldman Sachs Sticks to Their Buy Rating for Autolus Therapeutics (AUTL)
TipRanks·05/14 18:12
Autolus Therapeutics price target raised to $10 from $9 at H.C. Wainwright
Dow Jones·05/14 17:45
Autolus Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Benzinga·05/14 13:42
Autolus Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript
Benzinga·05/14 12:58
Autolus Therapeutics Sees FY2026 Sales $120.000M-$135.000M vs $130.062M Est
TipRanks·05/14 12:45
Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)
TipRanks·05/14 12:43
Autolus Therapeutics backs FY26 revenue view $120M-$135M, consensus $129.39M
Same Industry
Name/Symbol
Change%
Price